Has The Time Arrived To Buy This Mid Cap Stock-ENVX

Acrobull UK Advisory Services Ltd.

November 10			2025
Name	Ticker	Sector/Industry		Market Cap	Risk Factor
Enovix Corporation.	ENVX-NASDAQ	Industrials		$2.064 Billion	Medium

Enovix Corporation specializes in the design, development, and manufacturing of lithium-ion battery cells, both domestically in the U.S. and internationally. The company caters to a range of industries, including wearables, IoT, smartphones, computing, electric vehicles.

Recent Highlights

Recent Highlights- Smartphone Clients: The lead customer has initiated additional lifecycle testing following our design revision, underscoring the collaborative, multi-year partnership that is characteristic of pioneering architectural solutions. A second smartphone program is also progressing rapidly with another mobile industry client.

Secured Financing: The company successfully completed a shareholder-friendly warrant dividend and issued new convertible notes maturing in 2030. The proceeds are expected to support the development of Fab2 and further our trajectory toward positive cash flow. As of the third quarter of 2025, the company’s unaudited cash, cash equivalents, and marketable securities totaled $648 million.

Second Quarter 2026 Financial Highlights

For the reported period, revenue reached $8.0 million, showing significant growth compared to the previous periods, where revenue was $4.3 million and $3.7 million, respectively. This increase reflects positive momentum and a stronger performance in the company's sales and overall business activities during the current period.

Gross profit (loss) was $1.4 million, improving from a loss of $0.6 million and a profit of $2.0 million previously. This reflects a gross margin of 18%, compared to (15%) in the prior period—an improvement of 33 percentage points. Similarly, gross margin rose to 21% from (13%), representing a 34-point increase.

Operating expenses were $48.4 million, relatively consistent with $48.6 million in the previous period, reflecting a modest $0.2 million decrease. In another comparison, operating expenses increased to $31.5 million from $26.4 million, a $5.1 million rise.

The company reported a loss from operations of $47.0 million, an improvement from a loss of $49.3 million, representing a $2.3 million reduction in losses. In another period, the loss from operations widened slightly to $29.8 million from $26.9 million, a $2.9 million increase.

Adjusted EBITDA was ($21.4 million), compared to ($23.7 million) previously, reflecting a $2.3 million improvement.

Stock Observation-Looking ahead, the company expects continued growth in revenue as it builds on the positive momentum from the current period. With expanding customer relationships, increased product adoption, and ongoing investments in innovation, the company anticipates further strengthening of its sales performance in the coming quarters. The outlook remains optimistic as we work to capitalize on emerging opportunities across key markets and drive continued progress in our strategic initiatives.

Risk Involved- Financial performance of the company may have an impact on the company stock performance.

Considering all the factors and financials of the company Acrobull UK maintains Buy for the stock.

Disclaimer- Though our research is fundamentally and technically based on Acrobull UK only provides general advice on the stocks and it is imperative for the investors to do the risk assessment for themselves before investing as Acrobull UK would not be liable for any loss or profit arising out through the investment made by the investors on our recommendations.

It is also advisable for the investors to consult with Financial Advisor, Broker or to seek any legal assistance as the research conducted by Acrobull UK is factually based and recommendations are given in accordance with that, but it is imperative to understand that Acrobull UK does not guarantee returns.

Acrobull UK Recommendation Based on Evaluation

Current Market Price	$9.56 USD
Acrobull Recommendation	Buy
Target Price	$10.85 USD
RSI Level	42 RSI
Total Shares Outstanding	215.82 Million
Shares Held by Insiders Shares Held by Institutions Risk Factor Stop Loss	11.84% 42.55% Medium 5%